anti-HBV agents (Shenyang Pharmaceutical University/Beijing Institute of Pharmacology and Toxicology/The Institute of Radiation Medicine Academy of Military Medical Sciences/302 Military Hospital of China)
N/A
Report date: 2025/01/26 16:28:47
NME
Base Information
Drug Nameanti-HBV agents (Shenyang Pharmaceutical University/Beijing Institute of Pharmacology and Toxicology/The Institute of Radiation Medicine Academy of Military Medical Sciences/302 Military Hospital of China)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShenyang Pharmaceutical University
China Registration ClassN/A
Develop Information
Active CompaniesBeijing Institute for Drug ControlFifth Medical Center Of Pla General HospitalShenyang Pharmaceutical University
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A